Two Sigma Advisers’s NEOPHOTONICS CORP NPTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-473,351
Closed -$7.28M 2985
2021
Q4
$7.28M Sell
473,351
-178,600
-27% -$2.35M 0.02% 619
2021
Q3
$5.68M Buy
651,951
+44,800
+7% +$408K 0.01% 727
2021
Q2
$6.2M Buy
607,151
+123,100
+25% +$1.3M 0.02% 760
2021
Q1
$5.78M Buy
484,051
+19,700
+4% +$223K 0.02% 795
2020
Q4
$4.22M Sell
464,351
-2,700
-0.6% -$20.9K 0.01% 895
2020
Q3
$2.84M Sell
467,051
-275,200
-37% -$2.1M 0.01% 995
2020
Q2
$6.59M Buy
742,251
+364,000
+96% +$3.14M 0.02% 701
2020
Q1
$2.74M Buy
378,251
+33,600
+10% +$249K 0.01% 950
2019
Q4
$3.04M Buy
344,651
+9,100
+3% +$68.1K 0.01% 1040
2019
Q3
$2.04M Buy
335,551
+141,800
+73% +$797K 0.01% 1102
2019
Q2
$810K Buy
193,751
+147,600
+320% +$778K ﹤0.01% 1620
2019
Q1
$290K Buy
46,151
+34,851
+308% +$244K ﹤0.01% 2001
2018
Q4
$73K Buy
+11,300
New +$86.4K ﹤0.01% 2249
2017
Q4
Sell
-60,400
Closed -$336K 2424
2017
Q3
$336K Sell
60,400
-2,300
-4% -$15.5K ﹤0.01% 1886
2017
Q2
$484K Sell
62,700
-39,757
-39% -$336K ﹤0.01% 1810
2017
Q1
$923K Buy
102,457
+52,400
+105% +$546K ﹤0.01% 1620
2016
Q4
$541K Sell
50,057
-20,800
-29% -$277K ﹤0.01% 1834
2016
Q3
$1.16M Buy
+70,857
New +$997K ﹤0.01% 1286
2015
Q3
Sell
-33,057
Closed -$302K 2042
2015
Q2
$302K Sell
33,057
-14,100
-30% -$107K ﹤0.01% 1613
2015
Q1
$318K Buy
+47,157
New +$190K ﹤0.01% 1561

Other funds holding NPTN

Two Sigma Advisers's NPTN Position: Q1 2022 in Review

Two Sigma Advisers sold out of NEOPHOTONICS CORP (NPTN) in Q1 2022, closing a stake of 473,351 shares — an estimated $7.28M sold.

Two Sigma Advisers first reported a position in NPTN in Q1 2015 and held it in 20 quarters. The position peaked at $7.28M in Q4 2021. 143 funds tracked by Wall St. Rank hold NPTN as of Q1 2022.

  • Two Sigma Advisers reported no remaining NEOPHOTONICS CORP position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 473,351 NEOPHOTONICS CORP shares in Q1 2022, an estimated $7.28M.
  • Two Sigma Advisers first reported a position in NEOPHOTONICS CORP in Q1 2015 and held it in 20 quarters.
  • Two Sigma Advisers's NEOPHOTONICS CORP position peaked at $7.28M in Q4 2021.
  • 143 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.